Mid‐course sample size modification in clinical trials based on the observed treatment effect
暂无分享,去创建一个
[1] N. Schmitz. Optimal Sequentially Planned Decision Procedures , 1992 .
[2] L D Fisher,et al. Self-designing clinical trials. , 1998, Statistics in medicine.
[3] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[4] J. Denne,et al. ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER , 2000, Journal of biopharmaceutical statistics.
[5] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[6] Christopher Jennison,et al. Optimal asymmetric one‐sided group sequential tests , 2002 .
[7] M A Proschan,et al. Designed extension of studies based on conditional power. , 1995, Biometrics.
[8] Gernot Wassmer,et al. Basic concepts of group sequential and adaptive group sequential test procedures , 2000 .
[9] L Fisher,et al. Statistical Inference for Self‐Designing Clinical Trials with a One‐Sided Hypothesis , 1999, Biometrics.
[10] 丹後 俊郎,et al. Adaptive Group Sequential Designs for Clinical Trials , 2003 .
[11] J. Denne,et al. Sample size recalculation using conditional power , 2001, Statistics in medicine.
[12] W. Brannath,et al. Recursive Combination Tests , 2002 .
[13] Y Tsong,et al. Group sequential test strategies for superiority and non‐inferiority hypotheses in active controlled clinical trials , 2001, Statistics in medicine.
[14] G Wassmer,et al. A comparison of two methods for adaptive interim analyses in clinical trials. , 1998, Biometrics.
[15] H. Schäfer,et al. Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches , 2001, Biometrics.
[16] Z. Shun,et al. Type I error in sample size re‐estimations based on observed treatment difference , 2001, Statistics in medicine.
[17] J Röhmel,et al. An adaptive method for establishing a dose-response relationship. , 1995, Statistics in medicine.
[18] Michael A. Proschan,et al. Effects of assumption violations on type I error rate in group sequential monitoring , 1992 .
[19] G. Chi,et al. On Sample Size and Inference for Two‐Stage Adaptive Designs , 2001, Biometrics.
[20] A Whitehead,et al. Mid-trial design reviews for sequential clinical trials. , 2001, Statistics in medicine.
[21] J. Cui,et al. Nonparametric Estimation of a Delay Distribution Based on Left‐Censored and Right‐Truncated Data , 1999, Biometrics.
[22] G Y Chi,et al. The attractiveness of the concept of a prospectively designed two-stage clinical trial. , 1999, Journal of biopharmaceutical statistics.
[23] Sue-Jane Wang,et al. Modification of Sample Size in Group Sequential Clinical Trials , 1999, Biometrics.
[24] J. Cornfield. A BAYESIAN TEST OF SOME CLASSICAL HYPOTHESES- WITH APPLICATIONS TO SEQUENTIAL CLINICAL TRIALS , 1966 .
[25] W. Lehmacher,et al. Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.
[26] Michael A. Proschan,et al. A Unified Theory of Two-Stage Adaptive Designs , 2002 .
[27] P. Bauer,et al. Adaptive Two Stage Designs and the Conditional Error Function , 1999 .